JP2023551254A5 - - Google Patents
Info
- Publication number
- JP2023551254A5 JP2023551254A5 JP2023532127A JP2023532127A JP2023551254A5 JP 2023551254 A5 JP2023551254 A5 JP 2023551254A5 JP 2023532127 A JP2023532127 A JP 2023532127A JP 2023532127 A JP2023532127 A JP 2023532127A JP 2023551254 A5 JP2023551254 A5 JP 2023551254A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063118060P | 2020-11-25 | 2020-11-25 | |
| US63/118,060 | 2020-11-25 | ||
| PCT/US2021/060731 WO2022115535A1 (en) | 2020-11-25 | 2021-11-24 | Gene therapies for neurodegenerative disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023551254A JP2023551254A (ja) | 2023-12-07 |
| JPWO2022115535A5 JPWO2022115535A5 (https=) | 2024-12-04 |
| JP2023551254A5 true JP2023551254A5 (https=) | 2024-12-04 |
Family
ID=81754891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023532127A Pending JP2023551254A (ja) | 2020-11-25 | 2021-11-24 | 神経変性疾患のための遺伝子治療 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230405149A1 (https=) |
| EP (1) | EP4251276A4 (https=) |
| JP (1) | JP2023551254A (https=) |
| KR (1) | KR20230112672A (https=) |
| CN (1) | CN116670291A (https=) |
| AU (1) | AU2021386390A1 (https=) |
| CA (1) | CA3203006A1 (https=) |
| IL (1) | IL303156A (https=) |
| MX (1) | MX2023006153A (https=) |
| WO (1) | WO2022115535A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024258754A1 (en) * | 2023-04-18 | 2025-11-13 | Cornell University | Methods and apoe pharmaceutical compositions for the treatment and the prevention of alzheimers disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000023587A2 (en) * | 1998-10-16 | 2000-04-27 | Introgene B.V. | Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e |
| AU2001253233B2 (en) * | 2000-04-06 | 2006-12-07 | Kos Pharmaceuticals, Inc. | Compounds and methods for lowering cholesterol levels without inducing hypertriglyceridemia |
| JP6469000B2 (ja) * | 2012-05-18 | 2019-02-13 | ユニバーシティー オブ アイオワ リサーチ ファウンデーション | アミロイドの沈着を処置するための方法および組成物 |
| JP7616995B2 (ja) * | 2018-11-28 | 2025-01-17 | プリベイル セラピューティクス，インコーポレーテッド | 神経変性疾患のための遺伝子治療 |
| EP4065600A1 (en) * | 2019-11-25 | 2022-10-05 | Cornell University | Apoe gene therapy |
-
2021
- 2021-11-24 KR KR1020237020920A patent/KR20230112672A/ko active Pending
- 2021-11-24 EP EP21899082.8A patent/EP4251276A4/en active Pending
- 2021-11-24 AU AU2021386390A patent/AU2021386390A1/en not_active Abandoned
- 2021-11-24 WO PCT/US2021/060731 patent/WO2022115535A1/en not_active Ceased
- 2021-11-24 JP JP2023532127A patent/JP2023551254A/ja active Pending
- 2021-11-24 CA CA3203006A patent/CA3203006A1/en active Pending
- 2021-11-24 US US18/038,247 patent/US20230405149A1/en active Pending
- 2021-11-24 CN CN202180087728.0A patent/CN116670291A/zh active Pending
- 2021-11-24 MX MX2023006153A patent/MX2023006153A/es unknown
- 2021-11-24 IL IL303156A patent/IL303156A/en unknown